SEARCH
Current Location:
>
> This Story

starstarstarstarempty star (1)
Log in or Register to rate this News Story
Forward Printable StoryPrint Send us your Comments

Never Miss a Story

Sign up for email alerts

 

More Industry Headlines

Benefits you can see: redundant imaging is reduced with HIE's New research shows that health information exchange leads to more better care

FDA says AngioDynamics PICC location system is good enough to not need CT verification Could mean big win for manufacturer, while cutting down on CT scans

CMS modifies meaningful use requirements and eases burdens on providers Changes expected to come in spring 2015

Ohio could have 70,000 fewer emergency department visits if scope-of-practice laws lifted: study Many states have removed the laws but Ohio is lagging behind

Mount Sinai launches artificial pancreas research study "Artificial pancreas" app can prevent too low blood sugar levels in those with type 1 diabetes during sleep

Charles Townes, laser pioneer, passes away at age 99 Remembering the Nobel Prize-winning physicist

Siemens names Bernd Montag as new CEO of health care Current CEO, Hermann Requardt will step down as of Feb. 1

MedInformatix partners with Vestrum Health to make EHRs profitable for physicians Trying to pay off that new EHR system? Sell the anonymous data

Introducing the American Board of MR Safety Group aims to address rising incidence of MR accidents

AdvaMed survey details the negative impact of the medical device tax A look at the effect two years later

Regenerative medicine
to generate sales

Regenerative Medicine to Be a $20 Billion Industry by 2025

by Brendon Nafziger , DOTmed News Associate Editor
Explosive growth over the next decade in the field of regenerative medicine could aid medical device companies looking to develop "delivery systems" for cell therapies, according to an analysis released last week.

The market for technologies that repair the body now stands at $1.6 billion, but could swell to $15-20 billion over the next 15 years, says Arshad Ahmed, partner of Scientia Advisors, a biotech and medical consulting firm, in a global market review.

Story Continues Below Advertisement

We want to buy your Siemens Symphony or Avanto MRI -- today!

Top Dollar Paid, Fixed or Mobile. Call our Siemens Specialist for a Quote today -- 212-558-6600 Ext. 250 DOTmed Certified



While regenerative medicine conjures up mad-science images of growing batches of new organs or limbs - or even the infamous mouse with a human ear blooming on its back - the main focus of "regen" in the short-term will be on practical, specific clinical applications, Ahmed tells DOTmed News.

What these therapies might lack in sci-fi glamor, they make up for in potential clinical benefits to patients and time-saving in physicians' workflows.

For instance, currently, half of the revenues of regen comes from spine fusion applications, such as those supplied by Medtronic, says Ahmed.

These involve bone morphogenetic protein, or BMP, genetically modified human proteins that spur bone growth. It's delivered in a sponge or gel, and helps vertebrae fuse back together after certain kinds of spine surgeries.

Ahmed believes that BMP is a good model for future successful regen products, because it makes doctors' "workflow much simpler than the existing standard of care," he says.

BMP is only approved for some kinds of spinal fusion surgeries and a study last year suggested it was associated with a higher rate of complications. Still, Ahmed points out that it has been widely adopted by surgeons, because it has the potential to make "life much easier" by reducing the number of procedures performed in a back surgery.

For surgeries where doctors can use BMP, they can forgo the usual first step of removing a piece of the patient's hip bone, which they then have to grind to a powder and then re-inject into the patient's spinal cage during the surgery, to encourage healing - a role now taken over by BMP.

"The procedure is simpler and it takes less time for surgeons to do it, so they can see more patients," he says.

Patients like it, too, he notes, as they're spared an extra surgical step.

VASCULAR GROWTH

Over the short-term, Ahmed expects much of the new growth to be in peripheral vascular applications, where regen is helping the body repair damage to the vascular system.

One promising treatment possibly not too far from the clinic is being developed by Pervasis.

Continue reading Regenerative Medicine to Be a $20 Billion Industry by 2025...
  Pages: 1 - 2 - 3 >>

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.
Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Center
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2015 DOTmed.com, Inc.
ALL RIGHTS RESERVED